RESEARCH HIGHLIGHTS

Researchers at Heinrich Heine University and Forschungszentrum Jülich are using high-performance computing in tandem with experimental research to better understand a common, antibiotic-resistant infection prevalent in healthcare settings.

The mRNA vaccine for COVID-19 was the first of its kind, demonstrating the potential of a new biomedical paradigm. Computational research at the Johannes Gutenberg University Mainz could open new opportunities for mRNA-based medicines.

High-performance computing enables bioengineers to predict how laboratory results can be transferred to industrial conditions without loss of performance.

High-performance computing helps scientists at Heinrich Heine Universität Düsseldorf and Forschungszentrum Jülich better understand enzymes that are more resistant to detergents and solvents.